hims semaglutide out of stock Hims & Hers Health reported Q1 GAAP EPS of -$0.40 Hims & Hers Health (HIMS)

If a document is not turned over due to privilege, then the document is logged and the opposing side is informed that it exists

We deliver supplements that work as hard as you do, giving you the edge to push your limits and master your goals

By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)

(i) Sensitivity Analysis ASM participants will receive payment adjustments based on their final scores

Studies in GHD patients receiving hGH therapy report [15]: Improved quality of life 2-5% increase in lean muscle mass 7-10% lower fat mass and a -1.2inch mean decrease in waist circumference 11-16% lower LDL (bad) cholesterol Yet, the benefits of hGH therapy in otherwise healthy individuals appear to be more modest

VEGF induces vascularization around the HFs to promote hair growth (Zhang et al., 2020)